Evolve BioSystems in the Sacramento Business Journal
Evolve BioSystems Completes $20 Million Series B Financing
The Sacramento Business Journal reports on our Series B funding and our pursuit of restoring the newborn microbiome.
Devon Horse Show 2017- Join Evolve to learn more about GlycoGuard® for nursing foals
Evolve BioSystems announced today that it has completed a $20 million Series B financing to fund the commercialization of its initial infant health products.
ESPGHAN 2017- Visit Evolve Booth #10
Come join Evolve as we enjoy the Devon Horse Show, and to learn how our animal health product, GlycoGuard® supports a healthy gut microbiome in nursing foals.
PAS 2017- Join Evolve at Booth #302
Evolve BioSystems is thrilled to participate in the ESPGHAN Annual Meeting 2017, May 10-13th in Prague, Czech Republic.
Join Evolve at the Veterinary Innovation Summit 2017
Come visit the Evolve booth #302 to learn how we are Rescuing the Infant Gut Microbiome.
Evolve to Present at NEC Symposium 2017
The Veterinary Innovation Summit, an event co-hosted by Texas A&M University and the North American Veterinary Community (NVAC), is a collision of different ideas, technologies, organizations, and people all committed to advancing the future of the veterinary profession.
Dr. David Kyle to speak at the Microbiome R&D and Business Collaboration Congress: Asia
The NEC Symposium: A Transdisciplinary Approach to Improved Outcomes, will be cohosted by the NEC Society and UC Davis, and is the first national conference to bring together leading clinicians, researchers, parent advocates and others involved in the study of neonatal NEC.
The conference will bring together Pharma, Biotech, Academic Institutions and investors who are partnering together to develop and progress ground-breaking microbiome research into commercially viable products.